Skip to content

Achieve Life Sciences ACHV Granted (in shares)

Granted (in shares) at other companies

CNB Financial logo
CNB FinancialCCNE
0
Wingstop logo
WingstopWING
0
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
1.5M-12.6%
LivaNova logo
LivaNovaLIVN
957.7K+31.3%
The Hanover Insurance Group logo
The Hanover Insurance GroupTHG
148.1K+5.5%
Genpact logo
GenpactG
0

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's granted (in shares)?
Achieve Life Sciences (ACHV) reported granted (in shares) of 2.3M in Q1 2026.
How has Achieve Life Sciences's granted (in shares) changed year-over-year?
Achieve Life Sciences's granted (in shares) increased by 1755.3% year-over-year, from 124.5K to 2.3M.
What does granted (in shares) mean?
The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.